Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01760694 · ClinicalTrials.gov registry record · NA
Multi-Modality Therapy for Untreated Patients With Resectable or Marginally Resectable Pancreatic Cancer
A NA study, sponsored by Southwestern Regional Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT01760694 is a NA study that was terminated before completion, run by Southwestern Regional Medical Center. The registered enrollment target is 6 participants.
The verdict
NCT01760694, a NA study, was terminated before completion, sponsored by Southwestern Regional Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
To assess the ability of a combination of updated and approved modalities in the treatment of first line pancreatic cancer patients to increase the time to Progression Free Survival
Interventions
- OTHER Multi-Modality; IORT, Surgery, Radiation, Chemotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2013-01 |
| Est. Completion | 2014-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01760694
The ClinicalTrials.gov registry entry for NCT01760694 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Southwestern Regional Medical Center, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Multi-Modality; IORT, Surgery, Radiation, Chemotherapy is the first listed.
NCT01760694 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01760694 about?
NCT01760694 is a clinical study titled "Multi-Modality Therapy for Untreated Patients With Resectable or Marginally Resectable Pancreatic Cancer". To assess the ability of a combination of updated and approved modalities in the treatment of first line pancreatic cancer patients to increase the time to Progression Free Survival
What is the current status of trial NCT01760694?
This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2013-01. Estimated completion is 2014-07.
What interventions are being tested in trial NCT01760694?
The interventions under investigation include: Multi-Modality; IORT, Surgery, Radiation, Chemotherapy (OTHER).
Who is sponsoring clinical trial NCT01760694?
This trial is sponsored by Southwestern Regional Medical Center, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.